ADVM Financial Statements

Balance sheet, income statement, cash flow, and dividends for Adverum Biotechnologies Inc (ADVM).


$76.05M Market Cap.

As of 03/18/2024 5:00 PM ET (MRY) • Disclaimer

ADVM Market Cap. (MRY)


ADVM Shares Outstanding (MRY)


ADVM Assets (MRY)


Total Assets

$173.01M

Total Liabilities

$89.54M

Total Investments

$21.53M

ADVM Income (MRY)


Revenue

$3.60M

Net Income

-$117.17M

Operating Expense

$127.59M

ADVM Cash Flow (MRY)


CF Operations

-$90.90M

CF Investing

$96.88M

CF Financing

$69.00K

ADVM Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

ADVM Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$173,010,000 (-43.90%)

$308,372,000 (-29.87%)

$439,727,000 (-8.88%)

$482,567,000 (116.66%)

Assets Current

$102,773,000 (-46.08%)

$190,595,000 (-39.90%)

$317,145,000 (-27.00%)

$434,438,000 (147.02%)

Assets Non-Current

$70,237,000 (-40.36%)

$117,777,000 (-3.92%)

$122,582,000 (154.69%)

$48,129,000 (2.71%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$83,469,000 (-54.02%)

$181,518,000 (-42.59%)

$316,185,000 (-27.20%)

$434,347,000 (148.26%)

Property Plant & Equipment Net

$67,030,000 (-41.13%)

$113,861,000 (-4.37%)

$119,060,000 (152.78%)

$47,101,000 (2.74%)

Cash & Equivalents

$76,976,000 (8.52%)

$70,934,000 (93.29%)

$36,698,000 (-42.14%)

$63,423,000 (-5.19%)

Accumulated Other Comprehensive Income

-$473,000 (69.11%)

-$1,531,000 (-114.43%)

-$714,000 (-173.56%)

-$261,000 (64.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$21,526,000 (-81.63%)

$117,158,000 (-56.77%)

$270,993,000 (-26.22%)

$367,305,000 (266.80%)

Investments Current

$21,526,000 (-81.63%)

$117,158,000 (-56.77%)

$270,993,000 (-26.22%)

$367,305,000 (266.80%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$6,478,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,921,000 (-14.16%)

$2,238,000 (61.36%)

$1,387,000 (-50.64%)

$2,810,000 (-31.51%)

Accumulated Retained Earnings (Deficit)

-$919,777,000 (-14.60%)

-$802,612,000 (-23.85%)

-$648,076,000 (-28.96%)

-$502,536,000 (-30.52%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$64,627,000 (-30.93%)

$93,561,000 (-7.46%)

$101,108,000 (285.39%)

$26,235,000 (-7.01%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$64,627,000 (-30.93%)

$93,561,000 (-7.46%)

$101,108,000 (285.39%)

$26,235,000 (-7.01%)

Total Liabilities

$89,541,000 (-29.41%)

$126,854,000 (2.68%)

$123,542,000 (156.20%)

$48,220,000 (0.94%)

Liabilities Current

$24,914,000 (-22.74%)

$32,246,000 (51.25%)

$21,320,000 (2.15%)

$20,871,000 (7.54%)

Liabilities Non-Current

$64,627,000 (-31.69%)

$94,608,000 (-7.45%)

$102,222,000 (273.77%)

$27,349,000 (-3.57%)

ADVM Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$3,600,000 (0%)

$0 (0%)

$7,500,000 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$49,915,000 (-13.73%)

$57,858,000 (-10.22%)

$64,441,000 (44.35%)

$44,641,000 (57.32%)

Research & Development Expense

$77,676,000 (-21.76%)

$99,277,000 (11.32%)

$89,181,000 (21.65%)

$73,309,000 (81.37%)

Operating Expenses

$127,591,000 (-18.80%)

$157,135,000 (2.29%)

$153,622,000 (30.24%)

$117,950,000 (71.45%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$1,078,000 (-1556.76%)

$74,000 (0%)

$0 (0%)

$1,114,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$117,165,000 (24.18%)

-$154,536,000 (-6.18%)

-$145,540,000 (-23.86%)

-$117,507,000 (-82.22%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$117,165,000 (24.18%)

-$154,536,000 (-6.18%)

-$145,540,000 (-23.86%)

-$117,507,000 (-82.22%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$117,165,000 (24.18%)

-$154,536,000 (-6.18%)

-$145,540,000 (-23.86%)

-$117,507,000 (-82.22%)

Weighted Average Shares

$100,824,000 (1.58%)

$99,251,000 (1.24%)

$98,039,000 (15.14%)

$85,146,000 (32.83%)

Weighted Average Shares Diluted

$100,824,000 (1.58%)

$99,251,000 (1.24%)

$98,039,000 (15.14%)

$85,146,000 (32.83%)

Earning Before Interest & Taxes (EBIT)

-$118,243,000 (23.45%)

-$154,462,000 (-6.13%)

-$145,540,000 (-25.04%)

-$116,393,000 (-80.49%)

Gross Profit

$3,600,000 (0%)

$0 (0%)

$7,500,000 (0%)

$0 (0%)

Operating Income

-$123,991,000 (21.09%)

-$157,135,000 (-7.54%)

-$146,122,000 (-23.88%)

-$117,950,000 (-72.08%)

ADVM Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

$96,875,000 (-31.64%)

$141,720,000 (80.06%)

$78,709,000 (128.09%)

-$280,167,000 (-311.57%)

Net Cash Flow from Financing

$69,000 (-88.63%)

$607,000 (-74.68%)

$2,397,000 (-99.33%)

$355,985,000 (1162.76%)

Net Cash Flow from Operations

-$90,902,000 (15.90%)

-$108,091,000 (-0.24%)

-$107,831,000 (-35.99%)

-$79,291,000 (-61.26%)

Net Cash Flow / Change in Cash & Cash Equivalents

$6,042,000 (-82.35%)

$34,236,000 (228.10%)

-$26,725,000 (-669.51%)

-$3,473,000 (96.10%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$97,683,000 (-36.38%)

$153,536,000 (63.63%)

$93,832,000 (134.97%)

-$268,323,000 (-449.55%)

Capital Expenditure

-$808,000 (93.16%)

-$11,816,000 (21.87%)

-$15,123,000 (-27.68%)

-$11,844,000 (38.46%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$240,000 (-293.44%)

-$61,000 (45.54%)

Issuance (Purchase) of Equity Shares

$489,000 (-19.44%)

$607,000 (-76.98%)

$2,637,000 (-99.26%)

$358,089,000 (1102.73%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$17,569,000 (-12.50%)

$20,079,000 (-20.30%)

$25,194,000 (23.55%)

$20,391,000 (105.99%)

Depreciation Amortization & Accretion

$18,671,000 (186.01%)

$6,528,000 (40.54%)

$4,645,000 (11.71%)

$4,158,000 (164.34%)

ADVM Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

100.00%

-

100.00%

-

Profit Margin

-3254.60%

-

-1940.50%

-

EBITDA Margin

-2765.90%

-

-1878.60%

-

Return on Average Equity (ROAE)

-98.60% (-46.29%)

-67.40% (-68.50%)

-40.00% (-26.58%)

-31.60% (13.66%)

Return on Average Assets (ROAA)

-52.80% (-21.66%)

-43.40% (-42.76%)

-30.40% (-8.19%)

-28.10% (6.33%)

Return on Sales (ROS)

-3284.50%

-

-1940.50%

-

Return on Invested Capital (ROIC)

-73.90% (-61.71%)

-45.70% (-58.68%)

-28.80% (12.99%)

-33.10% (34.33%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.65 (-74.93%)

-0.37 (68.80%)

-1.19 (84.86%)

-7.86 (31.13%)

Price to Sales Ratio (P/S)

21.08

-

23.01

-

Price to Book Ratio (P/B)

0.91 (186.48%)

0.32 (-41.76%)

0.55 (-77.56%)

2.43 (-42.79%)

Debt to Equity Ratio (D/E)

1.07 (53.51%)

0.7 (78.77%)

0.39 (252.25%)

0.11 (-59.34%)

Earnings Per Share (EPS)

-1.16 (25.64%)

-1.56 (-5.41%)

-1.48 (-7.25%)

-1.38 (-36.63%)

Sales Per Share (SPS)

0.04 (0%)

0 (0%)

0.08 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.91 (24.67%)

-1.21 (3.67%)

-1.25 (-17.20%)

-1.07 (-0.28%)

Book Value Per Share (BVPS)

0.83 (-54.73%)

1.83 (-43.29%)

3.23 (-36.78%)

5.1 (86.92%)

Tangible Assets Book Value Per Share (TABVPS)

1.72 (-44.77%)

3.11 (-30.72%)

4.49 (-20.87%)

5.67 (63.11%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-2 (77.78%)

-9 (18.18%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.33 (24.43%)

-0.44 (75.35%)

-1.79 (80.07%)

-9 (18.36%)

Asset Turnover

0.02 (0%)

0 (0%)

0.02 (0%)

0 (0%)

Current Ratio

4.13 (-30.21%)

5.91 (-60.26%)

14.88 (-28.54%)

20.82 (129.70%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$91,710,000 (23.52%)

-$119,907,000 (2.48%)

-$122,954,000 (-34.91%)

-$91,135,000 (-33.21%)

Enterprise Value (EV)

$33,237,257 (-49.12%)

$65,323,970 (-74.14%)

$252,633,678 (-74.98%)

$1,009,714,217 (45.65%)

Earnings Before Tax (EBT)

-$118,243,000 (23.45%)

-$154,462,000 (-6.13%)

-$145,540,000 (-25.04%)

-$116,393,000 (-80.49%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$99,572,000 (32.69%)

-$147,934,000 (-5.00%)

-$140,895,000 (-25.54%)

-$112,235,000 (-78.40%)

Invested Capital

$135,747,000 (-54.56%)

$298,753,000 (-38.12%)

$482,817,000 (13.74%)

$424,508,000 (157.84%)

Working Capital

$77,859,000 (-50.83%)

$158,349,000 (-46.47%)

$295,825,000 (-28.47%)

$413,567,000 (164.32%)

Tangible Asset Value

$173,010,000 (-43.90%)

$308,372,000 (-29.87%)

$439,727,000 (-8.88%)

$482,567,000 (116.66%)

Market Capitalization

$76,053,257 (31.60%)

$57,792,970 (-66.54%)

$172,747,678 (-83.65%)

$1,056,657,217 (42.01%)

Average Equity

$118,773,750 (-48.19%)

$229,232,250 (-37.03%)

$364,036,750 (-1.98%)

$371,393,750 (110.70%)

Average Assets

$221,696,500 (-37.69%)

$355,770,750 (-25.80%)

$479,501,500 (14.85%)

$417,513,250 (94.38%)

Invested Capital Average

$160,018,250 (-52.63%)

$337,840,000 (-33.22%)

$505,868,750 (43.88%)

$351,602,750 (174.81%)

Shares

101,027,174 (1.30%)

99,729,025 (1.61%)

98,152,090 (0.69%)

97,477,603 (50.92%)